Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Lipomics Technologies, a clinical diagnostic development company, has entered into research collaboration with Joslin Diabetes Center.
Subscribe to our email newsletter
The collaboration will initially focus on two research programs. The first is a study on insulin resistant patients with a family history of type 2 diabetes. The primary objective is to identify predictive markers of disease that can be translated into blood based diagnostics. The second study will focus on understanding the effects of gastric bypass surgery on insulin sensitivity.
Lipomics will retain certain rights to develop diagnostic applications based on data emerging from these studies. Lipomics is developing diagnostic monitoring tools for the management of type 2 diabetes.